Jul 15, 2026 01:13PM
Jul 15, 2026 01:13PM
Jun 29, 2026 04:23AM
Jun 26, 2026 04:01PM
Jun 26, 2026 04:01PM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year
May 7, 2026 07:00AM
Mar 18, 2026 05:19AM
Mar 17, 2026 05:13PM
Mar 17, 2026 04:01PM
Mar 17, 2026 04:01PM
Mar 6, 2026 04:01PM
Mar 6, 2026 04:01PM Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Mar 2, 2026 08:32AM
Mar 2, 2026 08:30AM
Feb 26, 2026 04:25PM
Feb 26, 2026 07:00AM
Jan 2, 2026 08:00AM
Jan 2, 2026 08:00AM
Nov 6, 2025 07:02AM Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 6, 2025 07:00AM
Oct 30, 2025 08:31AM
Oct 30, 2025 08:30AM
Oct 28, 2025 08:33AM
Oct 28, 2025 08:30AM
Sep 24, 2025 04:51AM
Sep 24, 2025 01:00AM Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
Sep 11, 2025 08:14AM
Aug 6, 2025 07:00AM
Aug 6, 2025 06:45AM
Aug 6, 2025 06:45AM
Jul 22, 2025 09:13AM
Jul 22, 2025 08:55AM
Jul 22, 2025 07:00AM Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
Jul 22, 2025 07:00AM
Jun 11, 2025 04:01PM
May 7, 2025 07:00AM
May 6, 2025 04:01PM
May 6, 2025 04:01PM
Apr 30, 2025 08:30AM
Apr 30, 2025 08:30AM Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
Feb 26, 2025 07:00AM
Feb 15, 2025 10:00PM
Feb 5, 2025 08:30AM
Jan 28, 2025 06:15AM
Jan 28, 2025 06:00AM
Nov 11, 2024 07:41AM
Nov 11, 2024 07:39AM Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
Nov 6, 2024 07:00AM

325,890 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All